Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling. (26th April 2022)
- Record Type:
- Journal Article
- Title:
- Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling. (26th April 2022)
- Main Title:
- Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling
- Authors:
- Tait, Jessica R
Barnett, Timothy C
Rogers, Kate E
Lee, Wee Leng
Page-Sharp, Madhu
Manning, Laurens
Boyd, Ben J
Carapetis, Jonathan R
Nation, Roger L
Landersdorfer, Cornelia B - Abstract:
- Abstract: Background: Acute rheumatic fever (ARF), an autoimmune reaction to Group A Streptococcus ( Streptococcus pyogenes ; Strep A) infection, can cause rheumatic heart disease (RHD). New formulations of long-acting penicillins are being developed for secondary prophylaxis of ARF and RHD. Objectives: To evaluate the penicillin G concentrations required to suppress growth of Strep A. Methods: Broth microdilution MIC and MBC for Strep A strains M75 611024, M1T1 5448 and M18 MGAS8232 were determined. All strains were studied in a hollow fibre model (initial inoculum 4 log10 cfu/mL). Constant penicillin G concentrations of 0.008, 0.016 and 0.05 mg/L were examined against all strains, plus 0.012 mg/L against M18 MGAS8232 . Viable counts were determined over 144 h. Subsequently, all penicillin G-treated cartridges were emptied, reinoculated with 5 log10 cfu/mL and counts determined over a further 144 h. Mathematical modelling was performed. Results: MIC and MBC were 0.008 mg/L for all strains; small subpopulations of M75 611024 and M1T1 5448, but not M18 MGAS8232, grew at 1× MIC. Following the first inoculation, 0.008 mg/L achieved limited killing and/or stasis against M75 611024 and M1T1 5448, with subsequent growth to ∼6 log10 cfu/mL. Following both inocula, concentrations ≥0.016 mg/L suppressed M75 611024 and M1T1 5448 to <1 log10 cfu/mL from 6 h onwards with eradication. Concentrations ≥0.008 mg/L suppressed M18 MGAS8232 to <1 log10 cfu/mL from 24 h onwards with eradicationAbstract: Background: Acute rheumatic fever (ARF), an autoimmune reaction to Group A Streptococcus ( Streptococcus pyogenes ; Strep A) infection, can cause rheumatic heart disease (RHD). New formulations of long-acting penicillins are being developed for secondary prophylaxis of ARF and RHD. Objectives: To evaluate the penicillin G concentrations required to suppress growth of Strep A. Methods: Broth microdilution MIC and MBC for Strep A strains M75 611024, M1T1 5448 and M18 MGAS8232 were determined. All strains were studied in a hollow fibre model (initial inoculum 4 log10 cfu/mL). Constant penicillin G concentrations of 0.008, 0.016 and 0.05 mg/L were examined against all strains, plus 0.012 mg/L against M18 MGAS8232 . Viable counts were determined over 144 h. Subsequently, all penicillin G-treated cartridges were emptied, reinoculated with 5 log10 cfu/mL and counts determined over a further 144 h. Mathematical modelling was performed. Results: MIC and MBC were 0.008 mg/L for all strains; small subpopulations of M75 611024 and M1T1 5448, but not M18 MGAS8232, grew at 1× MIC. Following the first inoculation, 0.008 mg/L achieved limited killing and/or stasis against M75 611024 and M1T1 5448, with subsequent growth to ∼6 log10 cfu/mL. Following both inocula, concentrations ≥0.016 mg/L suppressed M75 611024 and M1T1 5448 to <1 log10 cfu/mL from 6 h onwards with eradication. Concentrations ≥0.008 mg/L suppressed M18 MGAS8232 to <1 log10 cfu/mL from 24 h onwards with eradication after both inoculations. Mathematical modelling well described all strains using a single set of parameter estimates, except for different maximum bacterial concentrations and proportions of bacteria growing at 1× MIC. Conclusions: In the absence of validated animal and human challenge models, the study provides guidance on penicillin G target concentrations for development of new penicillin formulations. … (more)
- Is Part Of:
- Journal of antimicrobial chemotherapy. Volume 77:Number 7(2022)
- Journal:
- Journal of antimicrobial chemotherapy
- Issue:
- Volume 77:Number 7(2022)
- Issue Display:
- Volume 77, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 77
- Issue:
- 7
- Issue Sort Value:
- 2022-0077-0007-0000
- Page Start:
- 1923
- Page End:
- 1930
- Publication Date:
- 2022-04-26
- Subjects:
- Anti-infective agents -- Periodicals
Chemotherapy -- Periodicals
615.58 - Journal URLs:
- http://jac.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/jac/dkac124 ↗
- Languages:
- English
- ISSNs:
- 0305-7453
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4939.100000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22265.xml